Mutual Funds

UTI Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

327.59 -2.36
NAV(₹) as on 7/7/2026

-0.72%
1D

12.64%
1Y

25.53%
3Y

14.32%
5Y

UTI Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.26	Launch Date: 01 Aug 2005
Exit Load: 1% on or before 30D, Nil after 30D	AUM: ₹ 1,307.98 Crs
Lock-in: Nil	Investing Style: Mid Growth
Portfolio Price To Book Value: 7.39	Min. Investment: SIP : ₹ NA Lumpsum : ₹ 5,000.00
Scheme Benchmark: NA
Fund Manager: Kamal Gada

FUND OBJECTIVE

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 30/6/2026		4.95 %		95.05 %

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.

8.54 %

Ajanta Pharma Ltd.

5.08 %

Divi's Laboratories Ltd.

4.74 %

Gland Pharma Ltd.

4.11 %

Caplin Point Laboratories Ltd.

4.02 %

Lupin Ltd.

3.77 %

Apollo Hospitals Enterprise Ltd.

3.52 %

Alkem Laboratories Ltd.

3.14 %

Dr. Reddy's Laboratories Ltd.

3.01 %

Max Healthcare Institute Ltd.

2.98 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

70.37 %

Hospital & Healthcare Servic

23.10 %

Medical Equipment/Supplies/A

1.03 %

Business Support

0.55 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2021-22	2022-23	2023-24	2024-25	2025-26
NAV (31/3/2026)	157.00	143.40	223.40	268.23	271.22
Net Assets (Rs Crores)	77,623.29	65,449.87	94,725.87	1,04,203.85	1,05,553.48
Scheme Returns(%)(Absolute)	12.06	-8.81	55.54	18.69	2.56
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	50/75	68/76	21/90	5/102	31/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 15.99 +-0.11	11/12/2023	₹ 560.17	17.41%	-	-	20.02%
Quant Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.29 +-0.07	17/7/2023	₹ 372.5	8.70%	-	-	20.20%
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 20.53 +-0.16	4/10/2023	₹ 2,362.44	19.82%	-	-	29.96%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.01 +-0.14	6/2/2024	₹ 664.02	16.71%	-	-	21.49%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.49 +0.06	6/12/2024	₹ 95.49	14.67%	-	-	9.18%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.97 +-0.07	27/12/2024	₹ 332.52	12.39%	-	-	6.28%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.49 +0.04	27/6/2025	₹ 544.17	4.28%	-	-	4.80%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.82 +-0.07	28/11/2025	₹ 310.92	-	-	-	8.18%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.48 +-0.15	8/11/2021	₹ 237.99	5.07%	19.28%	-	12.73%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 564.84 +0.62	5/6/2004	₹ 8,635.75	8.05%	20.86%	12.92%	20.03%